GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorio Reig Jofre SA (XMAD:RJF) » Definitions » Other Operating Expense

Laboratorio Reig Jofre (XMAD:RJF) Other Operating Expense : €79.7 Mil (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Laboratorio Reig Jofre Other Operating Expense?

Laboratorio Reig Jofre's Other Operating Expense for the three months ended in Dec. 2023 was €38.4 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €79.7 Mil.

Laboratorio Reig Jofre's quarterly Other Operating Expense increased from Jun. 2023 (€0.0 Mil) to Sep. 2023 (€41.4 Mil) but then declined from Sep. 2023 (€41.4 Mil) to Dec. 2023 (€38.4 Mil).

Laboratorio Reig Jofre's annual Other Operating Expense increased from Dec. 2021 (€112.5 Mil) to Dec. 2022 (€123.7 Mil) and increased from Dec. 2022 (€123.7 Mil) to Dec. 2023 (€138.5 Mil).


Laboratorio Reig Jofre Other Operating Expense Historical Data

The historical data trend for Laboratorio Reig Jofre's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Reig Jofre Other Operating Expense Chart

Laboratorio Reig Jofre Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 97.01 109.93 112.49 123.66 138.47

Laboratorio Reig Jofre Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.80 38.65 - 41.37 38.36

Laboratorio Reig Jofre Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €79.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratorio Reig Jofre Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Laboratorio Reig Jofre's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorio Reig Jofre (XMAD:RJF) Business Description

Traded in Other Exchanges
Address
Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.